Conversations on the New Wave of Innovative Therapy in Follicular Lymphoma: Implications for Personalized Medicine
0.50 hr(s) | CME
Specialty: Follicular Lymphoma
Therapeutic Area(s): Oncology
Release Date: April 5, 2021
Expiration Date: April 4, 2022
Location: Internet Activity Enduring
In this activity, two lymphoma experts discuss the newest treatment options for follicular lymphoma (FL). Hear what Drs. John Pagel and Ian Flinn have to say about recent evidence supporting a personalized approach to treating patients with relapsed FL, including the integration and use of novel targeted options, such as PI3K and EZH2 inhibitors. The experts also provide their insights on baseline factors that can help identify patients who may benefit from the use of such innovative agents, as well as safety management.